Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation
暂无分享,去创建一个
H. Kenmotsu | T. Naito | A. Ono | H. Murakami | Toshiaki Takahashi | A. Notsu | K. Wakuda | S. Omori | E. Miyawaki | T. Kawabata | Haruki Kobayashi | N. Nishioka | N. Mamesaya | M. Yabe | H. Kodama | T. Miyawaki